Top Reasons to read this Pharmaceutical Mergers and Acquisitions Report
Understand the Pharmaceutical Merger and Acquisition Environment: Learn what is driving the pharmaceutical merger strategies of top companies — and how other organizations are seeking suitors for their own sales.
Build a Competitive Deal-Making Process: Target the right deals with an M&A task force, implement a timeline that works for both sides, and track different types of financing across deals brokered by companies of different sizes.
Complete the Integration as Soon as Possible and Boost Productivity: Build an integration timeline, clarify roles and responsibilities in the new organization and reduce the impact of attrition.
Learn from the Past Pharmaceutical Merger Activity: We’ve vetted 75 pharmaceutical mergers and acquisitions to determine purchasing trends, including price/pipeline ratios, financing options and deal motivators.
Look into the Pharmaceutical Merger and Acquisitions Future: Gather perspectives and predictions on future deals from the managers who execute them.
Compare your Deal to Others: Use the deal profiles to compare metrics for 19 different deals, explore deal size, functional involvement in deal-making, timelines, challenges and employee retention.
Key Questions this Report Answers about Pharmaceutical Mergers and Acquisitions
- What are the proper stakeholders that should be involved int he decision-making process?
- What does an integration timeline look like?
- How can a company prepare for the cultural integration of a recently acquired company?
- How does a potential deal measure up against others?
- What is driving purchasing decisions of top pharma companies?
|Publication Date||October 2009|
|Charts / Graphics||110 +|